ISB Co-founder Dr. Lee Hood talks about his vision for “big data-driven health” and how it could revolutionize the healthcare industry, the psychological impact of longer lifespans for humans, and the earthquake AI has caused in health.
Can chronic disease be prevented with data clouds, AI, genome testing and more? Can we add 50 years to our lives? Doctors Leroy Hood and Nathan Price outline what medicine will look like in the next 5 years - including the bright future of treatments for Alzheimer’s, cancer, and heart disease.
Lee Hood and Nathan Price spoke with podcast hosts Robb Wilson and Josh Tyson about how AI and scientific thinking intersect with preventive medicine and longevity.
Body mass index (BMI) is a long-used health indicator, but it comes with a long list of negatives. ISB researchers developed biological BMI that generates a more useful, actionable and accurate molecular score.
Popular Mechanics interviewed ISB Co-founder and Professor Dr. Lee Hood for an article titled “Leroy Hood Wants To Show You How To Live for a Really, Really Long Time.” The story features Hood’s big-data approach and a focus on disease prevention – all in the quest to help us live longer.
In this wide ranging podcast interview, Lee Hood and Nathan Price discussed why we age and die, sick care vs. healthcare, chronological age, the gut microbiome, and much more.
Reporter Anahad O’Connor cited ISB Associate Professor and microbiome specialist Dr. Sean Gibbons. Gibbons comments on a study he wasn’t involved with, saying it is interesting as it indicates people can lose body weight and body fat by switching to a diet that targets their gut microbiomes, even without exercising more or cutting back on calories.
There is tremendous market and media frenzy around new Alzheimer’s disease drugs, but their efficacy is contested while the potential of prevention is untapped and underreported, Drs. Lee Hood and Nathan Price wrote.
Dax Shepard and Monica Padman interview Drs. Lee Hood and Nathan Price about their book, “The Age of Scientific Wellness,” and discuss how AI is changing the medical industry, how infectious disease has impacted our world, and more.
In this story in The Washington Post, the efforts of ISB Co-founder Dr. Lee Hood using systems biology and personalized medicine to predict and prevent dementia are highlighted.
Drs. Lee Hood and Nathan Price are interviewed to discuss how artificial intelligence can drastically change the medical patient experience.
Lee Hood was a guest on the Geekwire Podcast and discussed “The Age of Scientific Wellness,” the new book by Lee and Nathan Price.
Nathan Price talked about his book “The Age of Scientific Wellness” in an interview with author Matthew LaPlante for Utah Public Radio’s “Undisciplined” program.
Work by ISB President Jim Heath and collaborators at UCLA, PACT Pharma and beyond identified and analyzed the process by which immune cells “see” and react to cancer cells, providing valuable insights into why certain treatments may work for some patients but not for others.
The Wall Street Journal published an essay adapted from “The Age of Scientific Wellness,” a book authored by Drs. Lee Hood and Nathan Price.
Associate Professor Sean Gibbons was interviewed for a story detailing that bacteria of the microbiome are transmitted between many individuals, not just infants and their mothers, in ways that can’t be explained by their shared diet or geography.
Research by Inyoul Lee, Kai Wang and Lee Hood, Walter Reed Army Institute of Research, and other collaborators show that people who are currently suffering or face a high risk of post-traumatic stress disorder show particular patterns in four biomarkers measurable with a simple blood test.
ISB President Dr. Jim Heath was interviewed by Seattle Met and discussed his novel work identifying four predictive factors of long COVID.
On this podcast episode, Lee Hood and Nathan Price discuss their book, “The Age of Scientific Wellness,” the role of AI in improvising human lifespan, immunotherapy, NMN, gene editing, Alzheimer’s disease, and several other topics.
Using multiomic, blood-based biomarkers, ISB researchers developed signatures of obesity and metabolic disease that can find affected individuals more accurately than body mass index based on height and weight.